ATM serine-1981 phosphorylation is a plausible biomarker

Cell Cycle

Volumn 14, Issue 20, 2015, Pages 3207-3208

  Bakkenist, Christopher J ^a   Beumer, Jan H ^a   Schmitz, John C ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATM SERINE 1981; SERINE; UNCLASSIFIED DRUG; ATM PROTEIN, HUMAN; BIOLOGICAL MARKER; TUMOR MARKER;

BLOOD VOLUME; EDITORIAL; ENZYME ACTIVATION; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; STEREOTACTIC BODY RADIATION THERAPY; ANIMAL; BLOOD; DNA DAMAGE; NEOPLASMS; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BIOMARKERS; BIOMARKERS, TUMOR; DNA DAMAGE; HUMANS; NEOPLASMS; PHOSPHORYLATION; SERINE;

EID: 84953888266     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1084205     Document Type: Editorial

References (7)

1. Biomarkers Definitions Working. Clin Pharmacol Ther 2001; 69(3):89-95; PMID:11240971; http://dx.doi.org/10.1067/mcp.2001.113989
2. Dancey JE, et al. Clin Cancer Res 2010; 16(6):1745-55; PMID:20215558; http://dx.doi.org/10.1158/1078-0432.CCR-09-2167
3. Bakkenist CJ, et al. Oncoscience 2015; 2(5):542-54; PMID:26097887
4. Bakkenist CJ, Kastan MB. Nature 2003; 421 (6922):499-506; PMID:12556884; http://dx.doi.org/10.1038/nature01368
5. White JS, et al. Cell Cycle 2008; 7(9):1277-84; PMID:18418045; http://dx.doi.org/10.4161/cc.7.9.5961
6. Bakkenist CJ, et al. Oncotarget 2013; 4(8):1143-8; PMID:23900392
7. Stiff T, et al. EMBO J 2006; 25(24):5775-82; PMID:17124492; http://dx.doi.org/10.1038/sj.emboj.7601446